A novel signature based on pairwise PD-1/PD-L1 signaling pathway genes for predicting the overall survival in patients with hepatocellular carcinoma

Clin Transl Med. 2021 May;11(5):e431. doi: 10.1002/ctm2.431.

Authors

Enfa Zhao¹, Shimin Chen², Ying Dang³

Affiliations

¹ Department of Structural Heart Disease, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
² Department of Gastroenterology, Traditional Chinese Medical Hospital of Taihe Country, Taihe, China.
³ Department of Ultrasound Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

No abstract available

Publication types

Letter

MeSH terms

B7-H1 Antigen / metabolism*
Biomarkers, Tumor / metabolism*
Carcinoma, Hepatocellular / genetics
Carcinoma, Hepatocellular / metabolism
Carcinoma, Hepatocellular / pathology*
Humans
Liver Neoplasms / genetics
Liver Neoplasms / metabolism
Liver Neoplasms / pathology*
Programmed Cell Death 1 Receptor / metabolism*
Signal Transduction / genetics*
Survival Rate*

Substances

B7-H1 Antigen
Biomarkers, Tumor
CD274 protein, human
PDCD1 protein, human
Programmed Cell Death 1 Receptor